1. Introduction {#sec1-antioxidants-09-00123}
===============

The resins are nonvolatile products of plants, which include surface resins, naturally secreted by plants or internal resins, which can be obtained or collected from incisions. Their chemical composition includes flavonoids, terpenoids, and fatty substances that in some cases are protective barrier for the plant against the attack of some herbivores and other insects \[[@B1-antioxidants-09-00123]\]. A limited number of families including Fabaceae, Burseraceae, and Pinaceae stand out for their high resin production \[[@B1-antioxidants-09-00123]\]. Argentina's Andean region is the habitat of arid and semiarid land species belonging to the genera *Larrea*, *Zuccagnia*, and *Bulnesia* recognized for their high production of resins or exudates, of which there is a lack of knowledge about their potential as sources of biomolecules of pharmacological and industrial interest. Chemical studies carried out in the last decades have reported a limited number of metabolites. Plants exudates are known to possess several biological activities including antimicrobial, antioxidant, anthelmintic, and nematicidal \[[@B1-antioxidants-09-00123],[@B2-antioxidants-09-00123]\]. *Zuccagnia punctata* is used in Argentina, to treat injuries and bruises, as a disinfectant of wounds, a repellent of insects, for roof construction in rural areas, and as a vegetable fuel for cooking food. Medicinal plants form a primary means for treatment of various diseases in many parts of the world. In Argentine *Z. punctata* is "the medicinal plant", it has the largest number of studies of chemistry and biological activity, including antimicrobial, antioxidant, anti-mutagenic, anti-inflammatory, and cytoprotective activities \[[@B3-antioxidants-09-00123]\].

Principally their bioactivities evidenced have been associated on the basis of the major component (chalcones) \[[@B4-antioxidants-09-00123],[@B5-antioxidants-09-00123],[@B6-antioxidants-09-00123],[@B7-antioxidants-09-00123],[@B8-antioxidants-09-00123],[@B9-antioxidants-09-00123]\].Recently, a selective and reliable characterization of the botanical phenolic profile of *Z.punctata* collected in the northwestern regions of Argentina by liquid chromatography coupled to diode array detector and quadrupole-time of flight mass spectrometry (LC-DAD-Q-TOF-MS) system was reported, highlighting the identification of the major constituent of an ethanolic extract as 4′-hydroxy-2′methoxydihydrochalcone together with other chalcones, flavanones, and caffeic acid derivatives \[[@B10-antioxidants-09-00123]\].

The interest on the Andean plants is remarkable, because they represent a source very little explored that can offer extracts or biomolecules promising for the study and development of new drugs of pharmacological interest.

In the last decades, several extracts, decoctions, and infusions of medicinal plants and fruits native to Argentina and Chile have been analyzed using the more accurate and reliable quadrupole orbitrap spectrometer (Q-OT-MS), updating significantly the chemical composition in most of the species reported \[[@B11-antioxidants-09-00123],[@B12-antioxidants-09-00123],[@B13-antioxidants-09-00123],[@B14-antioxidants-09-00123],[@B15-antioxidants-09-00123],[@B16-antioxidants-09-00123],[@B17-antioxidants-09-00123],[@B18-antioxidants-09-00123],[@B19-antioxidants-09-00123]\].

In this work, the antioxidant and antibacterial effects complemented with the exhaustive polyphenolic profile of *Zuccagnia punctata* resin are reported, showing the presence of unique bioactive molecules of pharmacological and industrial interest.

2. Materials and Methods {#sec2-antioxidants-09-00123}
========================

2.1. Chemicals {#sec2dot1-antioxidants-09-00123}
--------------

Ultra-pure water (\<5 µg/L TOC, (Total Organic Carbon) was obtained from a water purification system Arium 126 61316-RO, plus an Arium 611 UV unit (Sartorius, Goettingen, Germany). Methanol (HPLC grade) and formic acid (puriss. p.a. for mass spectrometry) from J.T. Baker (Phillipsburg, NJ, USA) were obtained. Folin-Ciocalteu (FC) reagent, 2,2-diphenyl-1-picrylhydrazyl (DPPH), ferric chloride hexahydrate, 2,4,6-tris(2-pyridyl)-s-triazine, trolox, quercetin, gallic acid, DMSO, and HPLC standards (caffeic acid phenethyl ether (CAPE), galangin, morusin, naringenin, pinocembrin, rhamnetin and shikonin, with purity higher than 95% by HPLC) were purchased from Sigma-Aldrich Chem. Co. (St. Louis, MO, USA) or Extrasynthèse (Genay, France). Cefotaxime was from Argentia^®^ (Bristol-Myers Squibb, Buenos Aires, Argentina). Mueller-Hinton broth was provided by Laboratorio Britania (Buenos Aires, Argentina).

2.2. Plant Material {#sec2dot2-antioxidants-09-00123}
-------------------

The aerial parts of *Zuccagnia punctata* Cav. (Fabaceae, Caesalpinoideae) were collected in February 2015, on Iglesia district, province of San Juan (Argentina) at an altitude of 1800 m above sea level. A voucher specimen has been deposited at the herbarium of the Botanic Museum of Córdoba (CORD 1125), Universidad Nacional de Córdoba, Argentina.

2.3. Z. punctata Orange-Yellow Resin (ZpRe) {#sec2dot3-antioxidants-09-00123}
-------------------------------------------

The orange-yellow resin was obtained by dipping fresh aerial parts (500 g; 4L of dichloromethane grade HPLC, 1 min; the extraction procedure was done three times), filtered and evaporated under reduced pressure to yield a semisolid yellow-orange resin (10 ± 1% yield *w*/*w*). The ZpRe was stored in a freezer at −40 °C until its use to bioassays, phenolics, and flavonoids identification/quantification as well as in ultrahigh resolution liquid chromatography orbitrap MS analysis (UHPLC-PDA-OT-MS) analysis.

The main chalcones of *Z.punctata*: 2′,4′-dihydroxychalcone, 2′,4′-dihydroxy-3′-methoxychalcone and caffeic acid derivatives, 1-methyl-3-(3′,4′-dihydroxyphenyl)-propyl caffeic acid ester and 1-methyl-3-(4′-hydroxyphenil)-propyl caffeic acid ester were isolated and characterized by analysis of their spectroscopic data (^1^H and ^13^C NMR), which agree with those reported in the literature \[[@B3-antioxidants-09-00123],[@B6-antioxidants-09-00123]\].

2.4. UHPLC-DAD-MS Instrument {#sec2dot4-antioxidants-09-00123}
----------------------------

An UHPLC-high-resolution MS machine Thermo Dionex Ultimate 3000 system with PDA detector controlled by Chromeleon 7.3 software (Thermo Fisher Scientific, Waltham, MA, USA) hyphenated with a Thermo Q-Exactive MS focus (Thermo, Bremen, Germany) was used \[[@B16-antioxidants-09-00123]\].

2.5. LC Parameters and MS Parameters {#sec2dot5-antioxidants-09-00123}
------------------------------------

Liquid chromatography was performed using an UHPLC C-18 column (150 × 4.6 mm Acclaim, ID, 2.5 µm; Thermo Fisher Scientific, Bremen, Germany) at 25 °C, hyphenated with a Thermo Q-Exactive MS focus (Thermo, Bremen, Germany) was used. The detection wavelengths were 330,280, 254, and 354 nm, and photodiode array detectors were set from 200--800 nm. Solvent delivery was performed at 1 mL/min using ultra-pure water supplemented with 1% formic acid (A) and acetonitrile with 1% acid formic (B) and a program starting with 5% B at zero time, then maintained 5% B for 5 min, then changing to 30% B within 10 min, then maintaining 30% B for 15 min, then going to 70% B for 5 min, then maintaining 70% B for 10 min, and finally returning to 5% B in 10 min. and keeping this condition for twelve additional minutes to achieve column stabilization before next injection of 20 µL. For the analysis, 5 mg of the resin was dissolved in 2 mL of methanol, filtered through a 200-µm PTFE (polytetrafluoroethylene) filter, and 20 µL was injected in the instrument. Standards and the resin dissolved in methanol were kept at 10 °C during storage in the autosampler. The HESI II and Orbitrap spectrometer (Thermo, Bremen, Germany) parameters were optimized as previously reported \[[@B16-antioxidants-09-00123],[@B17-antioxidants-09-00123]\]. Additionally, relevant experimental parameters have been reported recently in detail \[[@B18-antioxidants-09-00123]\] The Q-Exactive 2.3 SP 2, Xcalibur 2.4 and Trace Finder 3.3 (Thermo Fisher Scientific, Bremen, Germany) were used for UHPLC mass spectrometer control and data processing, respectively.

2.6. Total Phenolic (TP) and Flavonoid (F) Content {#sec2dot6-antioxidants-09-00123}
--------------------------------------------------

The total phenolics and flavonoid content of ZpRe was determined by employing total phenols assay by Folin--Ciocalteu reagent and flavonoids by AlCl~3~ assay, both in microplate \[[@B18-antioxidants-09-00123]\]. The total phenolic was expressed as milligrams of gallic acid equivalents (GAE) per gram of extracts (mg GAE/g ZpRe). Flavonoids were expressed as milligrams of quercetin equivalents (QE) per gram of extracts (mg QE/g ZpRe). The values were obtained using a Multiskan FC Microplate Photometer (Thermo Scientific, Waltham, MA, USA), and are showed as the mean ± standard deviation (SD).

2.7. Antioxidant Activity {#sec2dot7-antioxidants-09-00123}
-------------------------

### 2.7.1. 2,2-Diphenyl-1-picrylhydrazyl Radical Scavenging Capacity Assay {#sec2dot7dot1-antioxidants-09-00123}

The Capacity of ZpRe to 2,2-Diphenyl-1-picrylhydrazyl Radical Scavenging (DPPH) was run by the following procedure: DPPH solution (20 mg/L) in methanol was mixed with ZpRe solution at concentrations of 1, 5, 10, 50, and 100 µg/mL \[[@B18-antioxidants-09-00123]\]. The reaction progress absorbance of the mixture was monitored at 515 nm using a Multiskan FC Microplate Photometer (Thermo Scientific, Waltham, MA, USA). The percentage of the DPPH decoloration was proportional to the five antioxidant concentrations, and the concentration responsible for a decrease in the initial DPPH concentration by 50% was defined and calculated as EC~50~ value, which is showed as the mean ± SD.

### 2.7.2. Ferric-Reducing Antioxidant Power Assay (FRAP) {#sec2dot7dot2-antioxidants-09-00123}

The FRAP assay was run in microplate, as previously reported methodology \[[@B18-antioxidants-09-00123],[@B20-antioxidants-09-00123]\]. Briefly, FRAP reagent and a methanolic solution of ZpRe resin (1 mg/mL) were mixed; simultaneously, a calibration curve was prepared by mixing FRAP reagent and Trolox solutions, at concentrations between 0 and 1 mmol/L. The absorbance values of mixtures were obtained in a Multiskan FC Microplate Photometer Results were obtained by linear regression from the FRAP-Trolox calibration plot and are showed in equivalent milligrams Trolox/g ZpReresin.

### 2.7.3. Trolox Equivalent Antioxidant Activity Assay (TEAC) {#sec2dot7dot3-antioxidants-09-00123}

TEAC assay was run in microplate, as following the previously reported methodology \[[@B18-antioxidants-09-00123],[@B21-antioxidants-09-00123]\]. Briefly, a ZpRe methanolic solution was mixed with 200 µL of ABTS, measuring their absorbance at 734 nm after 4 min. Results were obtained by linear regression from a calibration curve constructed with Troloxand are showed expressed as equivalent milligrams Trolox/g ZpRe resin.

### 2.7.4. Lipid Peroxidation in Erythrocytes {#sec2dot7dot4-antioxidants-09-00123}

The ability of the ZpReresin at three concentrations (100, 250, and 500 µg/mL) and of catechin at a single concentration (100 µg/mL) to inhibit lipoperoxidation in erythrocytes (LP), induced by tert-Butyl hydroperoxide, was determined. Relevant technical aspects of the trial have been reported recently in detail \[[@B15-antioxidants-09-00123],[@B18-antioxidants-09-00123]\]. The values obtained are expressed as percentages of lipid oxidation inhibition.

2.8. Antibacterial Activity {#sec2dot8-antioxidants-09-00123}
---------------------------

### 2.8.1. Microorganisms {#sec2dot8dot1-antioxidants-09-00123}

For antibacterial evaluation, were used strains from the American Type Culture Collection (ATCC, Rockville, MD, USA) and clinical isolates from Laboratorio de Microbiología, Hospital Marcial Quiroga, San Juan, Argentina (MQ).The panel comprised the following bacteria: *Staphylococcus aureus* methicillin-sensitive ATCC 29213, *Staphylococcus aureus* methicillin-resistant ATCC 43300, *Staphylococcus aureus* methicillin-resistant-MQ1, *Staphylococcus aureus* methicillin-resistant-MQ2, *Streptococcus agalactiae*-MQ3, *Streptococcus pyogenes*-MQ4, and *Escherichia coli* ATCC 25922.

### 2.8.2. Antibacterial Susceptibility Testing {#sec2dot8dot2-antioxidants-09-00123}

Minimum inhibitory concentration (MIC) of ZpRe and antibiotic Cefotaxime (Argentia^®^, Buenos Aires, Argentina) was carried outby broth microdilution techniques, in according to CLSI \[[@B22-antioxidants-09-00123]\]. The ZpRe was tested from 0.98 to 3000 µg/mL.using an inoculum of each bacterium adjusted to 5 × 10^5^ cells with colony forming units (CFU)/mL. The absorbances at 620 nm were determined in a Multiskan FC Microplate Photometer (Thermo Scientific, Waltham, MA, USA).

2.9. Statistical Analysis {#sec2dot9-antioxidants-09-00123}
-------------------------

The Duncan's test from InfoStat edition 2016 software (Universidad Nacional de Córdoba, Argentina) was run to determine potential significant differences (*p* \< 0.05) in the carried out assays

3. Results {#sec3-antioxidants-09-00123}
==========

3.1. UHPLC-PDA-OT-MS Analysis of the Orange-Yellow Resin From San Juan Province, Argentina {#sec3dot1-antioxidants-09-00123}
------------------------------------------------------------------------------------------

Fifty-one compounds were detected in ZpRe by UHPLC-PDA-OT-MS analysis, combining full mass spectra and MS^n^ experiments, of which fifty were tentatively identified including flavonoids, chalcones, caffeic acid derivatives, coumaric acid esters, naphthoquinone, xanthene's derivatives, trichocethenes; vedelianin derivatives, and others. Several phenolics compounds from ZpRe were rapidly identified using available standards. Thirty-one not previously reported updated the chemical composition of this species. The identification of unknown phenolic compounds xanthene's characteristics of this bioactive plant was possible from comprehensive analysis of the full scan mass spectra, base peaks chromatograms, and data-dependent scan experiment, since the orbitrap provided high-resolution and accurate mass product ion spectra from precursor ions that are unknown before and within a single run.

The molecular formula was obtained through high resolution accurate mass analysis (HRAM) and matching with the isotopic pattern. The acquisition of the data in the UHPLC-PDA-OT-MS analysis was developed using electrospray negative mode, because compounds with a phenolic OH lose easily the proton in electrospray ionization, giving very good and diagnostic parent ions and fragments.

The metabolome identification of the 50 tentatively identified compounds is developed below, highlighting the relevant information of the 31 compounds that are new reports for the species (See [Figure 1](#antioxidants-09-00123-f001){ref-type="fig"}, [Figure 2](#antioxidants-09-00123-f002){ref-type="fig"} and [Figure 3](#antioxidants-09-00123-f003){ref-type="fig"}, [Table 1](#antioxidants-09-00123-t001){ref-type="table"}, and [Supplementary Material Figure S1](#app1-antioxidants-09-00123){ref-type="app"} for some representative compounds and spectra S1 and S2).

### 3.1.1. Flavonoids {#sec3dot1dot1-antioxidants-09-00123}

Peak **2** with a \[M − H\]^−^ ion at *m*/*z*: 271.06010 was identified as naringenin (C~15~H~11~O~5~^−^) \[[@B23-antioxidants-09-00123]\], peak **3** as shikoniin (C~9~H~7~O~4~^−^; *m*/*z*: 287.09238) \[[@B24-antioxidants-09-00123]\]; peak **4** as afzelechin (C~15~H~13~O~5~^−^; *m*/*z*: 273.07575) \[[@B25-antioxidants-09-00123]\]; peak **6** as epiafzelechin (C~15~H~13~O~5~^−^; *m*/*z*: 273.07660) \[[@B26-antioxidants-09-00123]\]; peak **7** showing a \[M − H\]^−^ ion at *m*/*z*: 271.06110 was tentatively identified as an naringenin enantiomer (C~15~H~11~O~5~^−^); peak **8** was identified as 3,7-dihydroxiflavanone \[[@B10-antioxidants-09-00123]\]; Peak **9** was tentatively identified as 7,8-dihydroxiflavone \[[@B10-antioxidants-09-00123]\]; peak **10** was proposed as 5-Hydroxy-4′,7-dimethoxyflavanone \[[@B27-antioxidants-09-00123]\]; peak **11**, was identified as 3,7,8 trihydroxydihydroflavanone \[[@B10-antioxidants-09-00123]\]; peak **14** with a \[M − H\]^−^ ion at *m*/*z*: 271.06010 (C~15~H~13~O~4~^−^)was identified as guibourtinidol (2R,3S)-4′,7-Dihydroxyflavan-3-ol), (C~15~H~13~O~4~^−^) \[[@B28-antioxidants-09-00123]\]; peak **17** was assigned to 7,4′-dihydroxy-5methoxy flavanone \[[@B10-antioxidants-09-00123]\]; peak **18** is agree to dihydroxyflavanone \[[@B10-antioxidants-09-00123]\]; peak **19** with a \[M − H\]^−^ ion at *m*/*z*: 315.0511 was identified as rhamnetin (C~16~H~11~O~7~^−^) \[[@B29-antioxidants-09-00123]\]; peak **20** was identified as 3,7-dihydroxyflavone \[[@B10-antioxidants-09-00123]\]; peak **24** and **26** were identified as dihydroxyflavanone pinocembrin \[[@B3-antioxidants-09-00123],[@B10-antioxidants-09-00123]\]; and its pinocembrin isomer; showing both compounds similarly MS/MS compared with authentically reference compounds; peak **27** was identified as 3,5,7-trihydroxyflavone (galangin) compared with compound of reference standard \[[@B3-antioxidants-09-00123]\]; peak **33** was tentatively proposed as flavanone supported by UV signal at 287nm and MS/MS fragmentation (C~15~H~11~O~3~^−^; *m*/*z*: 239.07097); Peak **48** with a \[M − H\]^−^ ion at *m*/*z*: 389.17566 was identified as shinflavanone (C~25~H~25~O~4~^−^; UV signals 287 nm) \[[@B30-antioxidants-09-00123]\]; while peak **49** with a \[M − H\]^−^ ion at *m*/*z*: 419.1502 was identified as prenylated flavonoid morusin (C~25~H~23~O~6~^−^) \[[@B31-antioxidants-09-00123]\]; peak **50** was tentatively identified as 8-C-Prenyl-6″,6″-dimethylpyrano \[2″,3″:7,6\] flavanone (C~25~H~25~O~3~^−^; *m*/*z*: 373.18060); peak **51** with \[M − H\]^−^ ion at *m*/*z*: 389.17572 and UV signals (287 nm) was identified as 3,7-dihydroxyflavone (C~25~H~25~O~4~).

### 3.1.2. Chalcones {#sec3dot1dot2-antioxidants-09-00123}

Peaks **25** with a \[M − H\]^−^ ion at *m*/*z*: 253.08669 was identified as 2′-hydroxy-4-methoxychalcone (C~16~H~13~O~3~^−^), while peaks **34**, and **35** were identified as characteristics chalcones reported to *Z. punctata* 2′,4′-dihydroxychalcone and 2′,4′-dihydroxy-3′-methoxychalcone; both chalcones were determined by MS/MS experiment and compared with authentic reference compounds previously isolated \[[@B3-antioxidants-09-00123]\].

### 3.1.3. Caffeic Acid Derivatives {#sec3dot1dot3-antioxidants-09-00123}

Peak **12** was identified as 1-methyl-3-(3′,4′-dihydroxyphenil)-propyl caffeic acid ester by their MS/MS properties compared with authentic reference compounds previously isolated \[[@B7-antioxidants-09-00123],[@B10-antioxidants-09-00123]\]; while peaks **13** and **15** with a \[M − H\]^−^ ion at *m*/*z*: 343.11838 and 343.11870 respectively, were tentatively identified as 1-methyl-3-(3′,4′-dihydroxyphenil)-propyl caffeic acid ester isomers (C~19~H~19~O~6~^−^); peaks **21** was identified as 1-methyl-3-(4′-hydroxyphenil)-propyl caffeic acid ester by their MS/MS compared with authentically reference compounds previously isolated \[[@B7-antioxidants-09-00123],[@B10-antioxidants-09-00123]\]; in the same way, peak **22** was assigned to 2-methyl-3-(3-hydroxy-4′-methoxyphenyl)-propyl caffeic acid ester, while peak **23** is supported by its mass properties as an isomer of compound **21**; peak **28** was tentatively identified as recognized caffeic acid phenetyl ether; peak **42** was identified as 3,7-dimethyl-2,6-octadienyl caffeic acid ester; and peak **45** was identified as 3,7-dimethyl-2,6-octadienyl caffeic acid ester.

### 3.1.4. Coumaric Acid Esters {#sec3dot1dot4-antioxidants-09-00123}

Peak **29** was identified as 4′-terbutyloxyphenyl *p*-coumaric acid ester \[[@B10-antioxidants-09-00123]\], while peak **30** was tentatively proposed to 1-methyl-3-(4′-hydroxyphenyl)-propyl *p*-coumaric acid ester \[[@B10-antioxidants-09-00123]\]; peak **31** by identical MS/MS properties and UV signals (C~19~H~19~O~4~^−^; *m*/*z*: 311.1289; 231--308--347 nm) was identified as a isomer of compound **30**; and peak **37** was proposed supported by MS/MS fragmentation as isomer of compound **29**.

### 3.1.5. Xanthene's Derivatives, Trichothecenes; Vedelianin Derivatives, and Others {#sec3dot1dot5-antioxidants-09-00123}

Peak **5** with a \[M − H\]^−^ ion at *m*/*z*: 349.16456 was identified as trichothecene calonectrin (C~19~H~25~O~6~^−^) \[[@B32-antioxidants-09-00123]\]. Peak **16** with a \[M − H\]^−^ ion at *m*/*z*: 287.09232was identified as naphthoquinone derivative, shikoniin isomer (C~16~H~15~O~5~^−^).

Peak **32** with a \[M − H\]^−^ion at *m*/*z*: 349.16456 (C~15~H~13~O~3~^−^), was identified as dunnione. Peak **36** was identified as blestriarene B, with a \[M − H\]^−^ ion at *m*/*z*: 479.14891 (C~30~H~23~O~6~^−^) \[[@B33-antioxidants-09-00123]\].

Peak **38** with a \[M − H\]^−^ ion at *m*/*z*: 477.22717 (C~29~H~33~O~6~^−^) was identified as glyvenol (tribenoside).

Peaks **40**, **41**, **43**, **44**, and **47** are structurally related, were thus assigned based on their mass properties and characteristic UV signals as the hexahydroxanthene derivative vedelianin (peak 40; C~29~H~35~O~6~^−^; *m*/*z*: 479.24338) \[[@B34-antioxidants-09-00123]\] and some of its derivatives as follows: Peak **41** with a \[M − H\]^−^ ion at *m*/*z*: 495.23813 (C~29~H~35~O~7~^−^)was identified as hidroxivedelianin; peak **43** with a \[M − H\]^−^ ion at *m*/*z*: 495.23773 (C~29~H~35~O~7~^−^)was tentatively assigned to hidroxivedelianin isomer, peak **44**, was identified as a reduced vedelianin (C~29~H~33~O~6~^−^; *m*/*z*: 477.22769); while peak **47** (C~29~H~35~O~6~^−^; *m*/*z*: 479.24338) was assigned to other vedelianin isomer, supported by identical MS/MS. A proposed biosynthesis and structures of vedelianin and some derivatives in *Z punctata* are showed in [Figure 2](#antioxidants-09-00123-f002){ref-type="fig"}. Peak **46** was tentatively identified as lupinifolin \[[@B35-antioxidants-09-00123]\].

3.2. Total Phenolic and Flavonoid Contents and Antioxidant, and Antibacterial Activities {#sec3dot2-antioxidants-09-00123}
----------------------------------------------------------------------------------------

The orange-yellow resin from *Z.punctata* (ZpRe) displayed a stronger DPPH scavenging activity with an EIC~50~ 25.72 µg/mL, as well as an outstanding inhibition of lipid peroxidation in erythrocytes (70% percent at 100 µg ZpRe/mL), this was comparable to the value shown by the reference compound catechin (74% at 100µg/mL) ([Table 2](#antioxidants-09-00123-t002){ref-type="table"}) and to the values shown recently by others Andean species \[[@B14-antioxidants-09-00123],[@B15-antioxidants-09-00123],[@B18-antioxidants-09-00123]\]. Phenolic antioxidant compounds acting as free radical scavengers can delay or inhibit lipid oxidation processes. This protection of polyunsaturated fatty acids against free radical damage may explain or supports phenolic compounds as a valuable natural product with potential to improve human health \[[@B36-antioxidants-09-00123]\] Regarding FRAP and ABTS results, the ZpRe exhibited moderate effect in both trials. The ZpRe presented a high content of TP, with values of 391 mg GAE/g ZpRe, where as approximately eighty percent correspond to flavonoids (313 mg QE/g ZpRe).

Results of antibacterial activity are depicted in [Table S1 (Supplementary Material)](#app1-antioxidants-09-00123){ref-type="app"}.The ZpRe showed activity against Gram-positive bacteria, including *Staphylococcus aureus* methicillin-resistant ATCC 43300, *S. aureus* methicillin-resistant-MQ-1, *S. aureus* methicillin-resistant-MQ-2, *S. aureus* methicillin-sensitive ATCC 25923 and *Streptococcus pyogenes* (MICs values were between 125 and 250 µg/mL). However, the ZpRe resin was not active against most of the other strains tested (MIC values \>250 µg/mL).

The antioxidant, antimicrobial, and other biological activities have been associated, by several authors, with the content of flavonoids and chalcones and some specific flavonoids such as pinocembrin \[[@B3-antioxidants-09-00123],[@B4-antioxidants-09-00123],[@B5-antioxidants-09-00123],[@B6-antioxidants-09-00123],[@B7-antioxidants-09-00123],[@B8-antioxidants-09-00123],[@B9-antioxidants-09-00123]\]. In a previous study, the quantification of selected markers performed by HPLC-UV method, showed that the resin contains on average 3.18; 3.20; 16.04; and 12.84 g of pinocembrin (24), galangin (27), 2′,4′-dihydroxychalcone (34) and 2′,4′-dihydroxy-3′methoxychalcone (35) respectively, each quantified in 100 g of ZpRe \[[@B8-antioxidants-09-00123]\].

However, the full UHPLC-MS identification of thirty one biomolecules for the first time in this species (peaks 2--7, 13--16, 19, 23, 25, 26, 31--33, 36--41, 43, 44, 46--51), some of them showing a broad spectra of pharmacological properties, including antioxidant and antimicrobial, canprovide additional and relevant support for the activities displayed by ZpRe resin. [Figure 3](#antioxidants-09-00123-f003){ref-type="fig"} and [Figure S2](#app1-antioxidants-09-00123){ref-type="app"} show the structures of some newly reported compounds in the resin of this plant.

Pharmacological activities of naringenin (**2**), as therapeutic agent to treat different diseases, such as cancer, diabetes, cardiovascular diseases and neurological disorders, oxidative stress and inflammation have been extensively reported \[[@B37-antioxidants-09-00123],[@B38-antioxidants-09-00123]\]. Additionally, antibacterial activity against *Salmonella thypi*, *Staphylococcus aureus,* and *Escherichia coli* ATCC as well as their antinociceptive and anti-inflammatory effect in mice model, have been also reported \[[@B39-antioxidants-09-00123],[@B40-antioxidants-09-00123],[@B41-antioxidants-09-00123],[@B42-antioxidants-09-00123]\]. Furthermore, the free radical scavenging and antioxidant properties havebeen associated with improvements experienced by rats with diabetes type I treated with naringenin \[[@B43-antioxidants-09-00123],[@B44-antioxidants-09-00123]\]. The protective effect against metabolic diseases of naringenin is supported by its ability to scavenging some free radicals, by its ability to induce antioxidant enzymes and targeting on phosphoinositide 3-kinase/protein Kinase B/nuclear factors \[[@B38-antioxidants-09-00123]\]. These mechanisms are involved in the neuroprotective effect recently reported by Chandran et al. \[[@B45-antioxidants-09-00123]\].

Shikonin (3) have demonstrated a broad spectrum of relevant biological activities such as, antioxidant, anti-inflammatory, antithrombotic, antimicrobial, wound healing effects, as well as neuroprotective effects against cerebral ischemia/reperfusion injury associated or supported to its antioxidant properties \[[@B46-antioxidants-09-00123],[@B47-antioxidants-09-00123],[@B48-antioxidants-09-00123],[@B49-antioxidants-09-00123],[@B50-antioxidants-09-00123],[@B51-antioxidants-09-00123]\]. On the other hand, shikonin inhibited the proliferation of three human pancreatic cancer cell lines, and potentiated synergistically the cytotoxic effect of the gemcitabine a chemotherapeutic drug \[[@B52-antioxidants-09-00123]\].

Additionally, afzelechin (**4**), epiafzelechin (**6**), and some catechol derivatives have been extensively reported as antioxidant compounds. Moreover, in relation to the antioxidant properties of afzelechin (**4**) its neuroprotective effect related to glutamate-induced neurotoxicity in HT22 cells has been informed \[[@B53-antioxidants-09-00123],[@B54-antioxidants-09-00123],[@B55-antioxidants-09-00123],[@B56-antioxidants-09-00123]\].

Compound **25** (2-hydroxy-4--methoxychalcone) has been reported as antiangiogenic, antitumoral, glutathione S-transferase inhibitor, and as therapeutic agent to treat atherosclerosis. In addition, several epidemiological studies support the idea that regular consumption of fruits and vegetables rich in flavonoids reduces the risk of cardiovascular diseases \[[@B57-antioxidants-09-00123],[@B58-antioxidants-09-00123],[@B59-antioxidants-09-00123]\].

In the other hand, the strong antibacterial activity of blestriarene B (36) and its antibacterial activity against *Streptococcus mutans* and *Staphylococcus aureus* (with MICs values of 12.5 and 6.25 µg/mL respectively) has been also reported \[[@B33-antioxidants-09-00123]\].

Vedelianin (**40**) has been recently reported as a potent antiproliferative agent against several cancer cell lines \[[@B60-antioxidants-09-00123],[@B61-antioxidants-09-00123]\]. The potential of morusin (**49**) against human colon rectal cancer and human cell lung cancer has been informed by Chang Lee et al. \[[@B62-antioxidants-09-00123]\] and Park et al. \[[@B63-antioxidants-09-00123]\]. Also, the cytotoxic activity of lupinifolin (**46**) in the cell line P-388 \[[@B35-antioxidants-09-00123]\] was reported.

The tribenoside glyvenol, (**38**) was used clinically for hemorrhoidal disease associated with coagulation, inflammation, and wounds. Kikkawa et al. (2010) \[[@B64-antioxidants-09-00123]\] reported that tribenoside interacts with epidermal cells and regulates the expression and localization of laminins to help reconstruct basement membranes in wound healing of hemorrhoids. Evidence exists to recommend the use of tribenoside as a fast, effective and safe option for the local treatment of low-grade hemorrhoids \[[@B65-antioxidants-09-00123]\].

Regarding guibourtinidol (**14**), recently, the hepatoprotective activity and powerful antioxidant properties of *Cassia abbreviata* root extract, rich in (epi)-catechin, (epi)-afzelechin, (epi)-guibourtinidol, and (ent)-cassiaflavan monomers as well as their dimers and trimers has been reported \[[@B66-antioxidants-09-00123]\].

Caffeic acid phenethyl ester (CAPE, **28**) is a bioactive compound of propolis and the exudate extract. It is known that CAPE possesses antioxidant, anti-inflammatory, anticancer, and cytotoxic properties and is a versatile therapeutically active polyphenol and an effective adjuvant of chemotherapy \[[@B67-antioxidants-09-00123],[@B68-antioxidants-09-00123],[@B69-antioxidants-09-00123],[@B70-antioxidants-09-00123],[@B71-antioxidants-09-00123]\].

4. Conclusions {#sec4-antioxidants-09-00123}
==============

Fifty phenolics compounds were identified by ultrahigh resolution liquid chromatography orbitrap MS analysis (UHPLC-PDA-OT-MS). Thirty-one are reported for the first time, updating the knowledge of the chemical profile of this species. The importance of the biomolecules identified support its traditional use. Herein, more scientific data on bioactivity and chemistry is showed for this plant that increase its potential for sustainable applications and industrial interest that *Z. punctata* offers, a species that grows in semi-arid Andean areas.

J.G. and S.M. held fellowships from CONICET, Argentina. G.E.F. and B.L. are researchers from CONICET, Argentina.

The following are available online at <https://www.mdpi.com/2076-3921/9/2/123/s1>. Figure S1: (a--h). Full orbitrap MS spectra and structures of representative compounds 3, 4, 14, 28, 30, 40, 43, and 48. Figure S2: Structures of newly reported compounds to ZpRe. Table S1. Antimicrobial activity of ZpRe.

###### 

Click here for additional data file.

M.J.S., G.E.F., B.L., and A.T. conceived and designed the experiments; J.G., B.L., and S.M. performed the antioxidant, antimicrobial, and total phenolic and flavonoid content experiments; M.J.S. and J.B. analyzed the data of HPLC/MS. All authors wrote the paper, and read and approved the final manuscript. All authors have read and agreed to the published version of the manuscript.

This research was funded by CICITCA-UNSJ, PME-2015-0200 and PIO CONICET-SECITI Nº 022, Argentina. M.J.S. and J.B. received financial support from Fondecyt, Chile (Grant 1180059).

The authors do not have any conflicts of interest.

![UHPLC-MS (total ion current) chromatograms of ZpRe resin.](antioxidants-09-00123-g001){#antioxidants-09-00123-f001}

![Proposed biosynthesis and structures of Vedelianin and some derivatives in *Z punctata*.](antioxidants-09-00123-g002){#antioxidants-09-00123-f002}

###### 

Structures of some newly reported compounds in ZpRe resin.
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###### 

Resolution UHPLC-PDA-Q-Orbitrap identification of biomolecules from ZpRe resin.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Peak     Retention Time (min)   UV Max            Tentative Identification                                                  Elemental Composition \[M − H\]^−^   Theoretical Mass (*m*/*z*)   Measured Mass (*m*/*z*)   Accuracy(δ ppm)   MS^n^Ions
  -------- ---------------------- ----------------- ------------------------------------------------------------------------- ------------------------------------ ---------------------------- ------------------------- ----------------- -----------------------------
  **1**    1.33                                     unknown                                                                   C~16~H~15~O~5~                       85.00343                                                                 

  **2**    2.77                   279               Naringenin ^a^                                                            C~15~H~11~O~5~                       271.06110                    271.0601                  3.67              

  **3**    3.35                   279--367          Shikoniin ^a^                                                             C~16~H~15~O~5~                       287.09325                    287.0923                  3.40              

  **4**    3.65                   279               Afzelechin ^a^                                                            C~15~H~13~O~5~                       273.07575                    273.0766                  3.22              

  **5**    4.05                   \-                Calonectrin ^a^                                                           C~19~H~25~O~6~                       349.16456                    349.1654                  2.58              85.00342

  **6**    4.18                   279               EpiAfzelechin ^a^                                                         C~15~H~13~O~5~                       273.07575                    273.0766                  3.10              

  **7**    4.28                   287               Naringenin enantiomer ^a^                                                 C~15~H~11~O~5~                       271.06195                    271.0611                  3.67              151.0394:109.0286

  **8**    4.31                   287               3,7-dihydroxiflavanone                                                    C~15~H~11~O~4~                       255.06519                    255.0661                  3.67              151.0394:109. 0286

  **9**    4.61                   287               7,8-dihydroxiflavone                                                      C~15~H~11~O~4~                       255.06519                    255.0661                  3.11              237.0553

  **10**   5.12                   287               5-hydroxy-4′,7-dimethoxyflavanone                                         C~17~H~15~O~5~                       299.09140                    299.0929                  2.95              285.0403;179.0345, 135.0444

  **11**   5.38                   287               3,7,8-trihydroxydihydroflavanone                                          C~15~H~11~O~5~                       271.06010                    271.0610                  3.33              253.0503;225.0552;\
                                                                                                                                                                                                                                            197.0603;151.0029

  **12**   5.67                   234-292-325       1-methyl-3-(3′,4′-dihydroxyphenyl)-propyl caffeic acid ester              C~19~H~19~O~6~                       343.11761                    343.1187                  2.49              179.0344;161.0236;\
                                                                                                                                                                                                                                            135.0443

  **13**   5.88                   236-277-312       1-methyl-3-(3′,4′-dihydroxyphenyl)-propyl caffeic acid ester isomer ^a^   C~19~H~19~O~6~                       343.11761                    343.1183                  2.22              257.0818;179.0345;\
                                                                                                                                                                                                                                            151.0393;135.0444;\
                                                                                                                                                                                                                                            107.0494

  **14**   5.88                   236-277-312       Guibourtinidol ^a^                                                        C~15~H~13~O~4~                       257.08084                    257.0816                  3.10              179.0345;151.0393;\
                                                                                                                                                                                                                                            135.0444;107.0494

  **15**   6.14                   279--367          1-methyl-3-(3′,4′-dihydroxyphenil)-propyl caffeic acid ester isomer ^a^   C~19~H~19~O~6~                       343.11853                    343.1187                  2.66              287.0818;151.0393;\
                                                                                                                                                                                                                                            119.0495;107.0494

  **16**   6.14                   279--367          Shikoniin isomer ^a^                                                      C~16~H~15~O~5~                       287.09140                    287.0923                  3.18              151.0393;119.0495;\
                                                                                                                                                                                                                                            107.0494

  **17**   6.27                   285               7,4′-dihydroxy-5-methoxy-flavanone                                        C~16~H~13~O~5~                       285.07575                    285.0766                  3.19              149.9952;119.0495

  **18**   6.73                   287               Dihydroxyflavanone                                                        C~15~H~11~O~4~                       255.06519                    255.0669                  3.05              237.0553;209.0604;\
                                                                                                                                                                                                                                            195.0400

  **19**   6.91                   251--349          Rhamnetin ^a^                                                             C~16~H~11~O~7~                       315.04993                    315\. 0511                3.18              185.0034,146.93796

  **20**   7.18                   246-324-237       3,7-dihydroxyflavone                                                      C~15~H~9~O~4~                        253.05029                    253.0495                  2.99              208.0524;223.0326;\
                                                                                                                                                                                                                                            195.0447; 180.0576

  **21**   7.31                   277 314           1-methyl-3-(4′-hydroxyphenil)-propyl caffeic acid ester                   C~19~H~19~O~5~                       327.12357                    327.1227                  2.64              135.0443

  **22**   7.55                   242, 291--324     2-methyl-3-(3-hydroxy-4′-methoxyphenyl)-propyl caffeic acid ester         C~20~H~21~O~6~                       357.13409                    357.1332                  2.32              343.1104;193.0500;\
                                                                                                                                                                                                                                            179.0343;161.0237;135.0440

  **23**   7.70                   249-285-323       1-methyl-3-(4′-hydroxyphenil)-propyl caffeic acid ester isomer ^a^        C~19~H~19~O~5~                       327.12380                    327.1227                  3.01              179.0344;163.0394;\
                                                                                                                                                                                                                                            135.0443;119.0494

  **24**   8.04                   235-343           Pinocembrin                                                               C~15~H~11~O~4~                       255.06601                    255.0651                  3.23              227.0907;213.0503;\
                                                                                                                                                                                                                                            164.0109;151.0029;\
                                                                                                                                                                                                                                            123.0080

  **25**   8.54                   239--306          2′hydroxy-4-methoxychalcone ^a^                                           C~16~H~13~O~3~                       253.08592                    253.0866                  3.02              

  **26**   9.00                   291               Pinocembrin isomer ^a^                                                    C~15~H~11~O~4~                       255.06599                    255.0651                  3.17              227.0709;213.0553;\
                                                                                                                                                                                                                                            164.0109;145.0642;\
                                                                                                                                                                                                                                            123.0080

  **27**   9.14                   267-315-360       Galangin(3,5,7-trihydroxyflavone)                                         C~15~H~9~O~5~                        269.04579                    269.0453                  3.22              213.0551;169.0653

  **28**   9.39                   242-268-310-357   Caffeic acid phenetyl esther                                              C~17~H~15~O~14~                      283.09649                    283.0794                  3.38              

  **29**   9.61                   271               4′-terbutyloxyphenyl *p*-coumaric acid ester                              C~19~H~19~O~4~                       311.12866                    311.1286                  2.91              163.0394;119.0490

  **30**   9.67                   231-308\          1-methyl-3-(4′-hydroxyphenyl)-propyl *p*-coumaric acid ester              C~19~H~19~O~4~                       311.12779                    311.1289                  2.91              179.0344;163.0394;\
                                  347                                                                                                                                                                                                       134.0366;119.0490

  **31**   9.88                   231-308-347       1-methyl-3-(4′-hydroxyphenyl)-propyl *p*-coumaric\                        C~19~H~19~O~4~                       311.12866                    311.1289                  2.81              179.0344;163.0394;\
                                                    acid ester isomer ^a^                                                                                                                                                                   135.0444;119.0494

  **32**   10.80                  277--312          Dunnione ^a^                                                              C~15~H~13~O~3~                       241.08592                    241.0866                  2.98              

  **33**   10.88                  287               Flavanone \*                                                              C~15~H~11~O~3~                       239.07027                    239.0709                  2.91              197.0603;169.0653;\
                                                                                                                                                                                                                                            153.0186;135.0080;\
                                                                                                                                                                                                                                            121.0280

  **34**   10.90                  232--346          2′,4′-dihydroxychalcone                                                   C~15~H~11~O~3~                       239.07027                    239.0710                                    197.0603;169.0653;\
                                                                                                                                                                                                                                            153.0186;135.0080;\
                                                                                                                                                                                                                                            121.0280

  **35**   11.37                  232--345          2′,4′-dihydroxy-3′-methoxychalcone                                        C~16~H~13~O~4~                       269.08167                    269.0808                  3.08              

  **36**   11.77                  285               Blestriarene B ^a^                                                        C~30~H~23~O~6~                       479.14957                    479.14891                 1.36              

  **37**   11.91                  280--323          4′-terbutyloxyphenyl *p*-coumaric acid ester isomer ^a^                   C~19~H~19~O~4~                       311.12779                    311.1286                  2.71              179.0344;161.0237;\
                                                                                                                                                                                                                                            135.0442

  **38**   12.72                  283               Glyvenol ^a^                                                              C~29~H~33~O~6~                       477.22754                    477.2271                  0.78              

  **39**   12.95                  293               1-methyl-3-(3′,4′-dihydroxyphenil)-propyl caffeic acid ester isomer ^a^   C~19~H~19~O~6~                       343.11761                    343.1183                                    179.0344; 161.0238;\
                                                                                                                                                                                                                                            135.0444:\
                                                                                                                                                                                                                                            109.0286

  **40**   13.19                  280               Vedelianin ^a^                                                            C~29~H~35~O~6~                       479.24882                    479.2433                  1.17              

  **41**   13.47                  280               Hidroxivedelianin ^a^                                                     C~29~H~35~O~7~                       495.23773                    495.2381                  0.82              161.0238;135.0443;\
                                                                                                                                                                                                                                            109.0286

  **42**   13.93                                    3,7-dimethyl-2-octaenyl caffeic acid ester                                C~19~H~21~O~4~                       313.14344                    313.1443                  2.91              

  **43**   14.04                  267--357          hidroxivedelianin isomer ^a^                                              C~29~H~35~O~7~                       495.23785                    495.2377                  0.25              479.2432;239.0710;\
                                                                                                                                                                                                                                            179.0345;161.0238;\
                                                                                                                                                                                                                                            135.0442

  **44**   14.42                  285               Vedelianin reduced ^a^                                                    C~29~H~33~O~6~                       477.22717                    477.2276                  1.10              

  **45**   15.26                  285--320          3,7-dimethyl-2,6-octadienyl caffeic acid ester (geranyl Caffeate)         C~19~H~23~O~4~                       315.16993                    315.1600                  3.10              178.0265;134.0364;\
                                                                                                                                                                                                                                            133. 0289

  **46**   16.58                  289-320           Lupinifolin                                                               C~25~H~25~O~6~                       405.16965                    405.1754                  −1.27             

  **47**   16.58                  289               Vedelianin isomer ^a^                                                     C~29~H~35~O~6~                       479.24882                    479.2433                  1.17              

  **48**   16.89                  287               Shinflavanone ^a^                                                         C~25~H~25~O~4~                       389.17474                    389.1756                  2.37              371.1654

  **49**   17.39                  285               Morusin ^a^                                                               C~25~H~23~O~6~                       419.1502                     419.14891                 2.21              363.0873;179.0344;\
                                                                                                                                                                                                                                            151.0354;109.0286

  **50**   19.23                  291               8-C-Prenyl-6″,6″-dimethylpyrano \[2″,3″:7,6\] flavanone ^a^               C~25~H~25~O~3~                       373.19782                    373.1806                  2.09              

  **51**   19.68                  287               Shinflavanone isomer ^a^                                                  C~25~H~25~O~4~                       389.17474                    389.1757                  2.52              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ New reports for the species *Zuccagnia punctata*.
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###### 

Antioxidant assays and total phenolic and flavonoids content of ZpRe from *Z. punctata*.

  --------------------------------------- ---------------
  **Phenolics Content**                   **ZpRe**
  Total phenolics (mg GAE/g ZpRe)         391.40 ± 2.18
  Flavonoids (mg QE/g ZpRe)               313.18 ± 3.10
  **Antioxidant Assay**                   
  DPPH (EC~50~ in µg ZpRe/mL)             25.72 ± 1.51
  FRAP (mg TE/g ZpRe)                     1.74 ± 0.13
  TEAC (mg TE/g ZpRe)                     1.25 ± 0.01
  Percentage LP (at 100 µg ZpRe/mL)       70.14 ± 2.26
  Percentage LP (at 100 µg catechin/mL)   74.14 ± 1.25
  --------------------------------------- ---------------

No significant differences were found between the three samples. ANOVA (analysis of variance) followed by Dunett's comparison test was used (significance *p* \< 0.05). DPPH: (2,2-diphenyl-1-picrylhydrazyl; TEAC: trolox equivalent antioxidant activity assay; FRAP: ferric-reducing antioxidant power assay.
